Milestone Scientific Announces Its Milestone Medical Inc. Subsidiary Has Raised $1.5 Million From European Investors - Seite 2

Net proceeds from the financing will be used for growth capital, including hiring personnel, signing additional international distributors, and supporting the regulatory requirements of the Company.

Leonard Osser, Chief Executive Officer of Milestone Scientific, stated, "This timely financing provided by European investors will enable Milestone Medical Inc. to develop distribution channels throughout the world. Based on our proprietary platform technology, we believe these first two medical applications represent a significant market opportunity for both Milestone Medical Inc. and Milestone Scientific Inc. Our technology is based on a patented Dynamic Pressure Sensing® system (DPS®), intended to measure the density of body tissue and thus help a clinician know the location of a hypodermic needle during an injection. In applications that have already received clearance, the system utilizes computer controlled technology to provide real-time feedback to the medical practitioner, providing precision technology for administering a drug to a patient. We are pleased to have conducted this financing at the subsidiary level, which allows us to execute our strategy while minimizing dilution. This financing further validates our strategy of developing and launching new medical instruments based on Milestone Scientific's core CompuFlo ® technology."

Wojciech Gudaszewski, CEO of WDM Capital USA, LLC, commented, "We are pleased to have helped provide the capital necessary to help realize the full potential of this exciting precision drug delivery technology."

Shares of Milestone Medical, Inc. are expected to begin trading on the Warsaw Stock Exchange, the largest national stock exchange in Central and Eastern Europe and one of the fastest-growing exchanges in Europe, in late November 2013.

About WDM

WDM is Central and Eastern Europe's leading small cap investment bank. It has been listed on the Warsaw Stock Exchange since 2007. Over the past 6 years, WDM has taken over 50 companies public on the Warsaw Stock Exchange. It has raised over $150,000,000 in private equity, venture capital and public financing for its clients. WDM's investment management subsidiary, WDM Capital, manages a growing portfolio of some of the region's most promising micro caps. WDM's United States subsidiary, WDM Capital USA, provides access to CEE financing and investment opportunities for North American clients and North American financing and market access for CEE clients. For more information visit: www.wdmcapital.com.

About Milestone Scientific Inc.

Milestone Scientific Inc. (MLSS) is a leading medical research and development company that designs and patents innovative injection technology. Milestone's computer-controlled systems make injections precise, efficient, and virtually painless. For more information please visit our website: www.milestonescientific.com. The epidural and intra-articular medical instruments are currently investigational in the US.

Contact:
David Waldman or Natalya Rudman
Crescendo Communications, LLC
Email: [e-mail]
Tel: [phone]